Le Lézard
Classified in: Health
Subject: RCL

CORRECTION NOTICE: New Hampshire Laboratory Error Incorrectly Resulted in Recall of l?f Farms "Spice" Packaged Salad Greens: Recall Canceled


CONCORD, N.H., May 11, 2023 /PRNewswire/ -- The New Hampshire Department of Health and Human Services (DHHS) has determined that a laboratory error incorrectly caused last week's recall announcement concerning l?f Farms "Spice" Packaged Salad Greens. The products from l?f Farms are safe and the recall has been canceled.

On May 5, a press release was issued regarding a potential contamination of Escherichia coli O157 bacteria of a specific lot of l?f Farms "Spice" Packaged Salad Greens. Upon being informed, l?f Farms voluntarily initiated a recall of the potentially affected products, prioritizing the health and safety of their customers. Subsequent whole genome sequencing was conducted, which determined that the control sample and the l?f Farms sample were nearly identical, indicating that the initial lab results were inaccurate due to a contamination error within the lab itself.

"I wish to apologize to l?f Farms, their customers and the public for this unfortunate event," said Division of Public Health Services (DPHS) Director Tricia Tilley. "l?f Farms' quick and decisive actions put the health of their customers first. Their products are safe for consumers. We appreciate that l?f Farms has been a willing partner in this process. While this situation is unprecedented, our dedicated staff will embrace all corrective actions to ensure it will not occur again."

Shawn Jasper, State Commissioner of Agriculture, Markets and Food added: "After a two-day inspection of l?f Farms' facility and products, what we discovered was a company that operates at the highest level of food safety and integrity. We are working closely with the FDA and l?f Farms to make this right."

l?f Farms is a subsidiary of BrightFarms, a national leader in the booming indoor farming industry, which is transforming how produce is grown and delivered with its expanding network of high-tech, sustainable hydroponic farms.

"We are relieved to confirm that this was merely a lab mistake, and our product was never at risk. Customer health and safety remain our top priority. I'm immensely proud of our team's swift response and effective collaboration with FDA and state officials," said Steve Platt, CEO of BrightFarms.

With the recall canceled, l?f Farms "Spice" is returning to store shelves in Hannaford and Market Basket in Maine, Massachusetts, New Hampshire, New York, Rhode Island and Vermont. There is no longer any need for consumers who have purchased the l?f Farms "Spice" products to discard them or seek refunds from their place of purchase. Consumers with questions are encouraged to call l?f Farms at 1-866-857-8745 between 8:00am-6:00pm EDT or email [email protected] with the subject line: Recall.

The PHL has not experienced a false positive from routine testing that resulted in a voluntary recall in more than twenty years. DHHS is working closely with the U.S. Food and Drug Administration (FDA) to confirm the source of the contamination and will implement necessary protocol changes to ensure it is not repeated. DHHS has been in communication with l?f Farms, the NH Department of Agriculture, Markets and Food, and the FDA. Based on the results of the investigation of the contaminated sample, the PHL will implement corrective actions to protect consumers, manufacturers and food producers, and the general public.

This is a correction to the press release issued on May 4, 2023 with the headline: "l?f Farms Recalls "Spice" Packaged Salad Greens Because of Possible Health Risk."

SOURCE New Hampshire Department of Health and Human Services


These press releases may also interest you

at 07:05
Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on defined bacterial consortia, today announced that members of its executive team will participate at the following investor...

at 07:05
Alentis Therapeutics ("Alentis"), a clinical-stage biotechnology company developing treatments for organ fibrosis and Claudin-1 positive tumors, announced today that Dr. Alberto Toso has been appointed as Chief Scientific Officer effective...

at 07:05
Deciphera Pharmaceuticals, Inc. , a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that it has entered into a definitive merger...

at 07:05
bit.bio, the company coding human cells for novel cures, and a pioneer in the field of synthetic biology, today announces it will participate in an engaging fireside chat at SynBioBeta 2024 featuring Nobel Laureate Thomas Südhof and bit.bio founder...

at 07:05
Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that it plans to report its financial results for its fiscal second quarter...

at 07:05
Positive high-level results from the DESTINY-Breast06 Phase III trial showed that ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to...



News published on and distributed by: